24 . June , 2018 - Sunday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Progesterone

Big Image Pronouncation: (pro-JESS-ter-ohn)
Class: Progestin

Trade Names:
- Vaginal gel 4% (45 mg)
- Vaginal gel 8% (90 mg)

Trade Names:
- Vaginal gel 4% (45 mg)
- Vaginal gel 8% (90 mg)

Trade Names:
- Capsules 100 mg (micronized progesterone)
- Capsules 200 mg (micronized progesterone)

Trade Names:
Progesterone in Oil
- Injection 50 mg/mL

Mechanism of Action


Inhibits secretion of pituitary gonadotropins, thereby preventing follicular maturation and ovulation (contraceptive effect); inhibits spontaneous uterine contraction; transforms proliferative endometrium into secretory endometrium.



Rapidly absorbed from the GI tract (oral); rapidly absorbed (IM). T max is 1 to 2 hr (oral); 6.8 hr (8% gel); and 9.2 hr (90 mg IM). C max is 17.3 to 72.5 ng/mL (100 to 300 mg/day for oral).


Protein binding is 96% to 99%, primarily to serum albumin (50% to 54%) and transcortin (43% to 48%). Undergoes enterohepatic recycling and distributes into breast milk.


Metabolized in the liver to pregnanediols and pregnenolones metabolites, which are conjugated to glucuronide and sulfate metabolites.


Excreted in the kidney (50% to 60% metabolites), bile/feces (approximately 10% metabolites), and small amount as unchanged in the bile. The t ½ is approximately 2 to 3 hr (after first 6-hr oral ingestion) and approximately 8 to 9 hr thereafter (oral). Absorption t ½ is a few minutes (IM) and 25 to 50 hr (gel). Elimination t ½ is approximately 10 wk (IM) and 5 to 20 min (gel).


3 to 6 mo (IM, long-acting).

Special Populations

Renal Function Impairment

Use with caution and only with careful monitoring because metabolites are eliminated this way.

Severe liver insufficiency


Indications and Usage


Amenorrhea and abnormal uterine bleeding caused by hormonal imbalance in the absence of organic pathology (eg, uterine cancer).


Progesterone supplementation or replacement as part of an assisted reproductive technology (ART) treatment for infertile women with progesterone deficiency.


Prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women receiving conjugated estrogen tablets.

Capsules and gel

Use in secondary amenorrhea.


Hypersensitivity to progestins; thrombophlebitis, thromboembolic disorders, cerebral hemorrhage (or history of these disorders); impaired liver function; breast or genital organ cancer; undiagnosed vaginal bleeding; missed abortion; diagnostic test for pregnancy; pregnancy or suspected pregnancy.

Dosage and Administration


IM 5 to 10 mg/day for 6 to 8 consecutive days.

Adults (8% gel)

Intravaginal 90 mg once daily for women requiring progesterone supplementation. In women with partial or complete ovarian failure, who require progesterone replacement, 90 mg bid.

Functional Uterine Bleeding

IM 5 to 10 mg/day for 6 days.

Prevention of Endometrial Hyperplasia

PO 200 mg in the evening for 12 days, sequentially per 28-day cycle.

Secondary Amenorrhea

PO Single 400 mg dose in the evening for 10 days. Intravaginal 45 mg of 4% gel every other day for up to 6 doses. Women who fail to respond, 90 mg of 8% gel every other day for up to 6 doses.

General Advice

  • Because medication can cause drowsiness, administer prescribed dose in the evening.
  • Administer without regard to meals, but administer with food if GI upset occurs.
  • For intravaginal administration only. Not for dermal, ophthalmic, or oral administration.
  • Administer gel using prefilled disposable applicator.
  • Discard applicator after delivering dose. Do not save for future use.
  • Do not use concurrently with other intravaginal therapy. If other intravaginal therapy is used, administer at least 6 hr before or after progesterone vaginal gel.
  • For IM injection only. Not for intradermal, subcutaneous, or intra-arterial administration.
  • Do not administer if particulate matter, cloudiness, or discoloration is noted.
  • Rotate injection sites.


Store capsules, vaginal gel, and injection at controlled room temperature (59° to 86°F). Protect capsules from excessive moisture.

Drug Interactions

CYP3A4 inhibitors (eg, ketoconazole)

May inhibit progesterone metabolism, increasing plasma levels and the risk of side effects.

Laboratory Test Interactions

Altered metyrapone test; increased sulfobromophthalein retention and other hepatic function tests; increase in prothrombin factors VII, VIII, IX, and X; altered pregnanediol determination; increase in protein bound iodine and butanol extractable protein bound iodine; decrease in T3 uptake.

Adverse Reactions


Hypertension, palpitation, angina pectoris (less than 5%); syncope with and without hypotension.


Headache, depression, dizziness, worry, fatigue, emotional lability, irritability (at least 5%); confusion, somnolence, speech disorder, anxiety, impaired concentration, insomnia, personality disorder (less than 5%); asthenia, anorexia, increased appetite, nervousness (clinical trials); migraine, decreased libido.


Acne, verruca, wound debridement (less than 5%); pain at injection site, melasma, chloasma, photosensitivity.


Earache, nasal congestion, pharyngitis, abnormal vision (less than 5%).


Abdominal bloating and pain, nausea, vomiting, diarrhea (at least 5%); constipation (at least 2%); dry mouth, dyspepsia, gastroenteritis, hemorrhagic rectum, hiatus hernia (less than 5%); tooth disorder (clinical trials).


Breast tenderness, urinary problems, vaginal discharge, breast pain, vaginal dryness (at least 5%); breast carcinoma (at least 2%); leucorrhea, uterine fibroid, vaginal dryness, fungal vaginitis, vaginitis, UTI (less than 5%); breast enlargement (clinical trials); breakthrough bleeding, spotting, change in menstrual flow, amenorrhea, changes in cervical squamo-columnar junction and cervical secretions, vaginal candidiasis, pruritus vulvae, endometriosis, spontaneous abortion, pelvic infection.


Cholecystectomy (at least 2%); hepatitis, elevated transaminases (postmarketing); cholestatic jaundice.


Lymphadenopathy (less than 5%).


Edema, peripheral edema (less than 5%); increase or decrease in weight.


Joint or musculoskeletal pain, back pain (at least 5%); arthritis, leg cramps, hypertonia, muscle disorder, myalgia (less than 5%).


Upper respiratory tract infection, coughing (at least 5%); bronchitis, pneumonitis, sinusitis (less than 5%).


Hot flashes, chest pain, night sweats, swelling of hands and feet, viral infection (at least 5%); accidental injury, chest pain, fever (less than 5%); abscess, herpes simplex (less than 5%); increased sweating (clinical trials); anaphylaxis and anaphylactoid reactions, pyrexia, masculinization of female fetus.



Category X ; Category B ( Prometrium capsule).


Excreted in breast milk.


Safety and efficacy not established.


Carefully observe patients with history of depression.

Fluid retention

Use cautiously when conditions that might be affected by this factor are present (eg, asthma, cardiac or renal dysfunction, epilepsy).

Ophthalmic effects

Discontinue medication if there are any sudden changes in vision or other serious ophthalmic effects.

Peanut oil

Capsule contains peanut oil and should not be used in patients allergic to peanuts.

Thrombotic disorder

Discontinue if these conditions occur or are suspected.

Vaginal bleeding

With irregular vaginal bleeding, including breakthrough bleeding, nonfunctional causes should be considered and adequate diagnostic measures undertaken.

Patient Information

  • Explain name, dose, action, and potential side effects of drug.
  • Advise patient to read Patient Information leaflet before using the first time and with each refill.
  • Instruct diabetic patient taking estrogen and progesterone to monitor blood glucose more frequently when therapy is started and to inform health care provider of significant changes in readings.
  • Teach patient proper method of breast self-examination, and remind patient to perform monthly.
  • Instruct patient to immediately report any of the following symptoms to health care provider: pain in groin or calves; sharp chest pain, coughing blood, or sudden shortness of breath; crushing chest pain or heaviness in chest; abnormal vaginal bleeding; breast lumps; sudden severe headache; dizziness or fainting; tremors or seizure; vision or speech problems; weakness or numbness of arms or legs; severe abdominal pain; depression; yellowing of the skin or eyes; or persistent pain, pus, or bleeding at injection site.
  • Advise patient that drug may cause dizziness and/or drowsiness and to use caution while driving or performing other tasks requiring mental alertness, coordination, or physical dexterity until tolerance is determined.
  • Advise women to notify health care provider if pregnant, planning to become pregnant, or breastfeeding.
  • Advise patient that follow-up visits and examinations, including Pap smear, at least once a year, will be required to monitor therapy and to keep appointments.
  • Capsules
  • Advise patient to take prescribed dose in the evening to minimize problems with medication-induced drowsiness or dizziness.
  • Remind patient using progesterone for prevention of endometrial hyperplasia to take prescribed dose once daily for 12 days per 28-day cycle.
  • Remind patient using progesterone for treating secondary amenorrhea that prescribed dose is taken once daily for 10 days.
  • Advise patient to take each dose without regard to meals but to take with food if stomach upset occurs.
  • Vaginal Gel
  • Review instructions for preparing the applicator and administering the gel.
  • If gel will be used at altitudes above 762 m, review special instructions for preparing the applicator to prevent partial release of gel before vaginal insertion.
  • Instruct patient to discard applicator after use and not to save for future use.
  • Advise patient that gel should not be used at the same time as other intravaginal products. If other intravaginal therapy is being used, instruct patient to administer at least 6 hr before or after the progesterone vaginal gel.
  • Advise patient that small, white globules may appear as a discharge, even several days after using gel, but that this is normal and of no concern.
  • Advise patient to discontinue use and notify health care provider if vaginal irritation develops while using the medication.
  • Injection
  • Advise patient that injection will be prepared and administered by a health care provider in a medical setting.

Recent Drug Updates at DrugIndexOnline:

cevimeline cevimeline
Generic Name: cevimeline (se vi ME leen) Brand Names: Evoxac What is cevimeline? Cevimeline increases the secretions of the saliva and sweat glands in the body. Cevimeline is used to treat dry mouth in people with Sjogren's Syndrome. Cevimeline may also be used for purposes other than th more...

Chlordiazepoxide (oral only) Chlordiazepoxide (oral only)
Some commonly used brand names are: In the U.S.— Alprazolam Intensol 1 Ativan 12 Dalmane 9 Diastat 7 Diazepam Intensol 7 Dizac 7 Doral 16 Halcion 18 Klonopin 5 Librium 3 Lorazepam Intensol 12 Niravam 1 Paxipam 10 ProSom 8 Restoril 17 Serax 14 Tranxene-SD 6 Tranxene-SD Half Strength 6 Tran more...

Demadex Demadex
Generic name: Torsemide Brand names: Demadex Why is Demadex prescribed? Demadex is a diuretic drug. It flushes excess water from the body by promoting the production of urine. Demadex is prescribed to reduce the water retention and swelling that often accompany congestive heart failure, chronic more...

DHS Zinc Topical DHS Zinc Topical
Some commonly used brand names are: In the U.S.— Denorex Advanced Formula DermaZinc Baby DermaZinc Cream DermaZinc Scalp DermaZinc Shampoo DermaZinc Soap DermaZinc Spray DHS Zinc Head & Shoulders Dandruff Shampoo (Fine or Oily Hair) Head & Shoulders Dandruff Shampoo (Normal Hair) more...

Doxycycline Dental Doxycycline Dental
Some commonly used brand names are: In the U.S.— Atridox Category Antibacterial (dental) Description Doxycycline (dox-i-SYE-kleen) periodontal system contains the antibiotic doxycycline and is used to help treat periodontal disease (a disease of your gums), which is caused by bac more...

Fluvoxamine Fluvoxamine
Some commonly used brand names are: In the U.S.— Luvox In Canada— Luvox Category Antiobsessional agent antidepressant Description Fluvoxamine (floo-VOX-a-meen) is used to treat obsessive-compulsive disorder. This medicine may also be used for other conditions as determine more...

Griseofulvin Microsize Griseofulvin Microsize
Generic Name: Griseofulvin Microsize Oral Suspension (gri-see-oh-FULL-vin) Brand Name: Grifulvin VGriseofulvin Microsize is used for:Treating fungal infections of the scalp, body, foot (athlete's foot), nails, thigh (jock itch), or hair follicles (barber's itch). Griseofulvin Microsize is an ant more...

Metoclopramide Syrup Metoclopramide Syrup
Generic Name: Metoclopramide Syrup (meht-oh-KLOE-pra-mide) Brand Name: Generic only. No brands available.Metoclopramide Syrup is used for:Short term treatment of gastroesophageal reflux disease (GERD) in certain patients who do not respond to other therapy. It is used to treat symptoms of a certa more...